Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Portfolio Companies

Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Read More View Portfolio Companies
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More View Research Collaborations
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Read More
---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
---
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Funding Models

Sample from 2008 to April 2023:

Funding Models
Funding Model

Please note that the listed transactions are a sample of the types of deals that can be created as well as just a sampling of the companies we have worked with over the time period from 2008 to 2023.

Investment

With nearly three decades of experience in healthcare investment, Deerfield is positioned to deliver tailored funding and organizational support to help enable the development and commercialization across all verticals of healthcare.

Deerfield is willing to and can navigate complex situations and financing dynamics. We deploy senior investment professionals to lead transactions and tenured business executives to assist your management team in key strategic decisions.

Value-based care support

Medtech incubator

From research to clinic

Not an Offer or Solicitation. The videos or case studies found on this website are not an offer to sell, or a solicitation to buy, any security or instrument in, or to participate in any investment strategy with any funds, vehicles or accounts sponsored or managed by Deerfield Management Company, L.P. (“Deerfield”) or any portfolio company in which Deerfield’s investment vehicles have invested. These videos and case studies contain statements regarding the opinions, views and/or beliefs of Deerfield employees and portfolio company employees and directors, and are intended to be viewed by executives of companies that may become Deerfield portfolio companies and collaboration partners in the future. Deerfield has not received or provided any cash or non-cash compensation in exchange for these statements. Deerfield portfolio companies receive funding from affiliates of Deerfield. As a result of their relationship with Deerfield and/or the Deerfield portfolio company, the executives, directors, and/or founders of the Deerfield portfolio companies have an incentive to make positive statements about Deerfield, its investment vehicles, and affiliates. Other past or present Deerfield portfolio company executives or third parties may not necessarily share the same opinions, views or beliefs about Deerfield as those expressed in these videos and case studies. Deerfield makes no representation or warranty as to the accuracy or completeness of the information in these videos and case studies. The information is subject to change without notice or update. It should not be assumed that the portfolio companies discussed in these videos and case studies were or will be profitable or that any future portfolio companies will be profitable.

With deep expertise and capabilities in the healthcare sector, we can inform your business strategy, and provide services to allow your management team to focus on the business of the company. These include:

Strategic advice from the Deerfield investment team

Research conducted by the Deerfield Institute and Deerfield Analytics on the commercial landscape

Support from Deerfield External Operations to manage and build key business functions (Contract Negotiation, HR, IR, IT, Communications)

Deerfield offers access to scientific and technical expertise to bolster your company’s R&D engine and connect you with other cutting-edge innovators in healthcare.

Deerfield Discovery and Development (3DC) is our in-house suite of biopharma experts with skillsets across the drug development spectrum.

Deerfield’s collaborations with healthcare experts of leading universities and academic research centers represent additional assets that can support your development and business goals.

Deerfield’s CURE, an innovation ecosystem for start-ups and entrepreneurs, provides opportunities for networking, expertise development, and access to talent and innovation as a resident or as a collaborator.


Funding Models

Deerfield tailors flexible financing options designed to meet the needs of its corporate partners most optimally. Some of our funding options can be seen here:


Contact Us

Karen Heidelberger

Partner, Chief Partnerships Officer
917.592.1388
[email protected]

Women in Science

Launched in 2019 by Deerfield, the Women in Science Translational Research Symposia were created to clarify the process and route to commercialization for women scientists and in turn, help prepare them to advance their discoveries to market. The program is committed to promoting diversity of perspectives in innovation and changing this paradigm through knowledge and network creation.

In 2022, the Women in Science Translational Research Symposia  formally embedded within Advancium Health Network, an independent non-profit organization launched by Deerfield Management and the Deerfield Foundation and continues to be supported by all three organizations.

External Operations Team

New and growing enterprises face the challenge of simultaneously executing complex business strategies, building world-class operating teams, creating partnerships, and a wide range of other critical functions with limited resources. The Deerfield External Operations team partners with newly formed, and existing management teams, providing a suite of services designed to enhance company success and growth while reducing timelines to value-creating events and overall costs.  While many companies require significant support early in the life cycle, the External Operations team is structured in a manner that allows Deerfield to be a long-term partner, offering services and assistance to businesses across all stages of maturity, from formation to a successful monetization event.

Services provided by the Deerfield External Operations team, include:

Fellowships

Beginning in 2015, Deerfield started the Deerfield Fellows program, designed to attract students with interest in pursuing healthcare or finance fields from local NYC-area colleges and universities from diverse backgrounds for an immersive summer internship program. Successful summer interns are invited to stay through a yearlong Deerfield Fellowship program, with the most successful of those graduating to become Associates at Deerfield. We are extremely proud of the work our Associates do.

About Deerfield

Advancing healthcare® through investment, information, and philanthropy.

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care. As of December 2023, the firm manages more than $14.6 billion in assets.

Providing value beyond capital, Deerfield generally maintains a combined portfolio of more than 200 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Having many years of operational expertise, Deerfielders are highly engaged and adept at navigating the complex crosscurrents ever-present in the healthcare and financial industries.

Collaboration, intellectual curiosity and pragmatism drive Deerfield’s approach. With its holistic view, Deerfield tailors flexible financing options designed to meet the needs of entrepreneurs and corporate partners.

Deerfield Investment
Supporting companies across the healthcare ecosystem with flexible funding models and value beyond capital.
Deerfield Institute
Delivering market research to the Deerfield team, its portfolio companies and other partners.
Deerfield Foundation
A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Value beyond capital

Pioneering a model of partnership with academic institutions which creates the potential for rapid funding and advancement of promising therapies. Learn more

Partnering with leading academic research centers to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease. Learn more

The Deerfield External Operations team partners with newly formed, and existing management teams, providing a suite of services designed to enhance company success and growth while reducing timelines to value-creating events and overall costs. Learn more

Programs

Deerfield and Oxeon founded the Break into the Boardroom program (BiB) based on a shared belief that their organizations are uniquely positioned to not only cultivate new female board candidates but to also connect these women with concrete governance opportunities.
Learn more

Launched in 2019, the Women in Science Translational Research Symposia were created to clarify the most targeted route to commercialization for female scientists and help advance their discoveries to market. The program is committed to addressing the gender gap in innovation and changing this paradigm through knowledge and network creation.

Beginning in 2015, Deerfield started the Deerfield Fellows program, designed to attract students with interest in pursuing healthcare or finance fields from local NYC-area colleges and universities from diverse backgrounds for an immersive summer internship program. Successful summer interns are invited to stay through a yearlong Deerfield Fellowship program, with the most successful of those graduating to become Associates at Deerfield. We are extremely proud of the work our Associates do.
CURE.
At CURE. — Deerfield’s innovation campus on 345 Park Avenue South — we’re transforming healthcare. Here, innovators from across the industry and around the world work shoulder to shoulder to develop treatments to eliminate deadly diseases and create new healthcare delivery models to lower cost and improve care for those in need.
Discover our mission

Deerfield Institute

Established in 2006, the Deerfield Institute delivers sophisticated and timely market research, which enhances the insights available to the investment team and its partners. The Institute develops and analyzes data to advance understanding of innovations and emerging products, and it also informs on trends within the healthcare market. It has published important scientific findings in peer-reviewed journals to extend learnings to the scientific community and benefit public health at large—and  ultimately patients in need. The Institute is guided by Deerfield’s core values: integrity, the pursuit of objective and unbiased research, commitment to excellence, precision and accuracy.

Deerfield Institute Capabilities: 

PUBLICATIONS
We publish research data to help advance healthcare and to enable researchers to have access to recent, relevant information.
View latest publications

Confidentiality

Deerfield Institute believes that market research is a valuable resource to the growing healthcare industry. A critical component of this research is assuring respondents that their information is being used properly and within standard industry guidelines. Individual responses from any market research effort are kept confidential and are reported without individual identifying information. During our research process, we collect, aggregate, and analyze information from respondents in various healthcare-related fields. We then prepare reports based on these answers for the purposes of understanding market level dynamics.

When participating in Deerfield Institute market research, respondents may be asked to provide personally identifiable information (such as name, email, and mailing address). This information will only be used to provide respondents with services or information that they have requested. When preparing reports or analyzing the results of our market research, personally identifiable information is always removed and will not be given or sold to a third party without the respondent’s consent.

All Deerfield Institute research is conducted in compliance with the Health Insurance Portability and Accountability Act (HIPAA).

As part of our research process we seek the insight of key opinion leaders and other expert advisors in the healthcare field. Our compliance framework is designed to avoid the receipt by Deerfield Institute of confidential information and strict policies and procedures must be followed in the engagement of these advisors. All paid advisors are required to sign terms and conditions that clearly define their responsibility to not disclose information to which they have a duty of confidence.

All Deerfield participants in an advisor interaction are trained in our compliance procedures and are required to give compliance reminders to expert consultants prior to each interaction. These policies and procedures extend to all of our partners that facilitate access to our advisors.

Deerfield Foundation

An affiliate of Deerfield Management, the Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to strive to improve health, accelerate innovation and promote human equity. Since its inception in 2007, the Foundation has formed numerous partnerships and invested in the advancement of children’s health, from clinics in the South Bronx to Nepal. Funds are provided through employee contributions and directly from Deerfield’s profits.

2023 Deerfield Foundation Program Committee

Mark Veich, Executive Director

Kerri Seacord, Treasurer

Julianna Santamaria, Executive Assistant

Abdul Khan, Program Committee Member

Adam Grossman, Program Committee Member

Ankita Shah, Program Committee Member

Bhumika Patel, Program Committee Member

Cecilia Perez, Program Committee Member

Chris Freeland, Program Committee Member

Danielle Rosato, Program Committee Member

David Griffith, Program Committee Member

Elise Wang, Program Committee Member

Emma Giegerich, Program Committee Member

Gabby Briganti, Program Committee Member

George Lytle, Program Committee Member

Giselle Pineda, Program Committee Member

H.C. Huang, Program Committee Member

Huijun Wang, Program Committee Member

Ivo Lorenz, Program Committee Member

John Limanto, Program Committee Member

Kate Lazar, Program Committee Member

Lisa Nordfors, Program Committee Member

Lizzy Baer, Program Committee Member

Luci Albertson, Program Committee Member

Mark Shtilerman, Program Committee Member

Mike Hurley, Program Committee Member

Moses Adubi, Program Committee Member

Nehan Chatoor, Program Committee Member

Nelson Barriocanal, Program Committee Member

Nicole Delgado, Program Committee Member

Rachel Chapin, Program Committee Member

Saiyara Fahmi, Program Committee Member

Sam Becker, Program Committee Member

Terence Fox-Karnal, Program Committee Member

Tori Fleek, Program Committee Member

Research Collaborations

Deerfield Management recognizes that investigators at research institutions provide much of the novel insights that advance our understanding of disease. However, at any research institution, the most commercially promising innovations eventually outgrow the lab, requiring greater resources and more focused development expertise than a research setting can typically provide.

To bridge that gap, Deerfield partners with leading research centers from across the country, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Together with its research partners, Deerfield has created 20 spin-off companies to date that are supporting key avenues from concept to spin-out of novel therapeutic discoveries, as well as an incubator focused on innovative cardiovascular devices.

Baylor College of Medicine
Blue Square Discoveries
Beth Israel Deaconess Medical Center
Brookline Avenue Innovations
Boston Children’s Hospital
Blackfan Circle Innovations
Broad Institute
Broad Institute
Cold Spring Harbor Laboratory
Harbor Discoveries
Columbia University
Hudson Heights Innovations
Dana-Farber Cancer Institute
Riverway Discoveries
Dana-Farber Cancer Institute
The Center for Protein Degradation
Duke University
Four Points Innovation
Empire Discovery Institute
Empire Deerfield Discovery and Development
Harvard University
Lab1636
MD Anderson Cancer Center
Vescor Therapeutics
Memorial Sloan Kettering Cancer Center, Rockefeller University, Weill Cornell Medicine
Bridge Medicines
Moffitt Cancer Center
Bayfield Therapeutics
Northwestern University
Lakeside Discovery
NYU Langone Health
Amethyst Innovations 
Stanford University
Porter Alliance for Innovative Medicines
The Johns Hopkins University
Bluefield Innovations
University of California San Diego
Poseidon Innovation
University of Illinois at Chicago
West Loop Innovations
University of Michigan
Great Lakes Discovery
University of North Carolina at Chapel Hill
Pinnacle Hill
Vanderbilt University
Ancora Innovation
Washington University in St. Louis
VeritaScience
Yeda | Weizmann Institute of Science
Orchard Innovations

Far beyond its financial resources—with its long vision, operational expertise, and command in the life science and healthcare space for more than two decades, Deerfield is uniquely positioned to support all stages of development from early-stage to market—advancing science and enabling the translation of ideas into medicines.

Deerfield Discovery and Development (3DC)

Researchers at academic institutions discover many of the novel insights that advance our understanding of disease. Commercially promising innovations eventually outgrow the lab, requiring greater resources and more focused development expertise than an academic setting can typically provide. To address this need, Deerfield has pioneered a model of partnership through research collaborations, which creates the potential for rapid funding and advancement of promising therapies.

Deerfield Discovery and Development (3DC) plays a critical role in progressing early-stage therapeutics from scientific discovery through preclinical proof of concept and into the clinic, via design and execution of relevant experiments. 3DC partners closely with principal investigators in Deerfield’s academic collaboration network, corporate partners and entrepreneurs to provide deep functional expertise and experience across key disciplines. These include: